The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland

Publisher's version (útgefin grein) Vaccinations with the 10-valent pneumococcal conjugated vaccine (PHiD-CV) started in Iceland in 2011. Protein D (PD) from H. influenzae, which is coded for by the hpd gene, is used as a conjugate in the vaccine and may provide protection against PD-positive H...

Full description

Bibliographic Details
Published in:Journal of Clinical Microbiology
Main Authors: Sveinsdóttir, Hildigunnur, Björnsdóttir, Jana Birta, Erlendsdóttir, Helga, Hjálmarsdóttir, Martha Ásdís, Hrafnkelsson, Birgir, Haraldsson, Ásgeir, Kristinsson, Karl G., Haraldsson, Gunnsteinn
Other Authors: Læknadeild (HÍ), Faculty of Medicine (UI), Lífvísindasetur (HÍ), Biomedical Center (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, University of Iceland
Format: Article in Journal/Newspaper
Language:English
Published: American Society for Microbiology 2019
Subjects:
Online Access:https://hdl.handle.net/20.500.11815/1931
https://doi.org/10.1128/JCM.00116-19
id ftopinvisindi:oai:opinvisindi.is:20.500.11815/1931
record_format openpolar
spelling ftopinvisindi:oai:opinvisindi.is:20.500.11815/1931 2023-05-15T16:49:37+02:00 The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland Sveinsdóttir, Hildigunnur Björnsdóttir, Jana Birta Erlendsdóttir, Helga Hjálmarsdóttir, Martha Ásdís Hrafnkelsson, Birgir Haraldsson, Ásgeir Kristinsson, Karl G. Haraldsson, Gunnsteinn Læknadeild (HÍ) Faculty of Medicine (UI) Lífvísindasetur (HÍ) Biomedical Center (UI) Heilbrigðisvísindasvið (HÍ) School of Health Sciences (UI) Háskóli Íslands University of Iceland 2019-05-08 https://hdl.handle.net/20.500.11815/1931 https://doi.org/10.1128/JCM.00116-19 en eng American Society for Microbiology Journal of Clinical Microbiology;57(7) https://syndication.highwire.org/content/doi/10.1128/JCM.00116-19 Sveinsdóttir H, Björnsdóttir JB, Erlendsdóttir H, Hjálmarsdóttir MÁ, Hrafnkelsson B, Haraldsson Á, Kristinsson KG, Haraldsson G. 2019. The effect of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine on H. influenzae in healthy carriers and middle ear infections in Iceland. J Clin Microbiol 57:e00116-19. https://doi.org/10.1128/JCM.00116-19. 0095-1137 1098-660X (eISSN) https://hdl.handle.net/20.500.11815/1931 Journal of Clinical Microbiology doi:10.1128/JCM.00116-19 info:eu-repo/semantics/openAccess Bólusetningar Inflúensa info:eu-repo/semantics/article 2019 ftopinvisindi https://doi.org/20.500.11815/1931 https://doi.org/10.1128/JCM.00116-19 2022-11-18T06:51:57Z Publisher's version (útgefin grein) Vaccinations with the 10-valent pneumococcal conjugated vaccine (PHiD-CV) started in Iceland in 2011. Protein D (PD) from H. influenzae, which is coded for by the hpd gene, is used as a conjugate in the vaccine and may provide protection against PD-positive H. influenzae. We aimed to evaluate the effect of PHiD-CV vaccination on H. influenzae in children, both in carriage and in acute otitis media (AOM). H. influenzae was isolated from nasopharyngeal swabs collected from healthy children attending 15 day care centers in 2009 and from 2012 to 2017 and from middle ear (ME) samples from children with AOM collected from 2012 to 2017. All isolates were identified using PCR for the hpd and fucK genes. Of the 3,600 samples collected from healthy children, 2,465 were culture positive for H. influenzae (68.5% carriage rate); of these, 151 (6.1%) contained hpd-negative isolates. Of the 2,847 ME samples collected, 889 (31.2%) were culture positive for H. influenzae; of these, 71 (8.0%) were hpd negative. Despite the same practice throughout the study, the annual number of ME samples reduced from 660 in 2012 to 330 in 2017. The proportions of hpd-negative isolates in unvaccinated versus vaccinated children were 5.6% and 7.0%, respectively, in healthy carriers, and 5.4% and 7.8%, respectively, in ME samples. The proportion of hpd-negative isolates increased with time in ME samples but not in healthy carriers. The number of ME samples from children with AOM decreased. The PHiD-CV had no effect on the proportion of the hpd gene in H. influenzae from carriage, but there was an increase in hpd-negative H. influenzae in otitis media. The proportions of hpd-negative isolates remained similar in vaccinated and unvaccinated children. This study was funded by The Icelandic Centre for Research (grant number 152047-051) and the Landspitali University Hospital Research Fund. The collection of DCC samples was part of an investigator-initiated study, supported by GlaxoSmithKline Biologicals SA. ... Article in Journal/Newspaper Iceland Opin vísindi (Iceland) Journal of Clinical Microbiology 57 7
institution Open Polar
collection Opin vísindi (Iceland)
op_collection_id ftopinvisindi
language English
topic Bólusetningar
Inflúensa
spellingShingle Bólusetningar
Inflúensa
Sveinsdóttir, Hildigunnur
Björnsdóttir, Jana Birta
Erlendsdóttir, Helga
Hjálmarsdóttir, Martha Ásdís
Hrafnkelsson, Birgir
Haraldsson, Ásgeir
Kristinsson, Karl G.
Haraldsson, Gunnsteinn
The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
topic_facet Bólusetningar
Inflúensa
description Publisher's version (útgefin grein) Vaccinations with the 10-valent pneumococcal conjugated vaccine (PHiD-CV) started in Iceland in 2011. Protein D (PD) from H. influenzae, which is coded for by the hpd gene, is used as a conjugate in the vaccine and may provide protection against PD-positive H. influenzae. We aimed to evaluate the effect of PHiD-CV vaccination on H. influenzae in children, both in carriage and in acute otitis media (AOM). H. influenzae was isolated from nasopharyngeal swabs collected from healthy children attending 15 day care centers in 2009 and from 2012 to 2017 and from middle ear (ME) samples from children with AOM collected from 2012 to 2017. All isolates were identified using PCR for the hpd and fucK genes. Of the 3,600 samples collected from healthy children, 2,465 were culture positive for H. influenzae (68.5% carriage rate); of these, 151 (6.1%) contained hpd-negative isolates. Of the 2,847 ME samples collected, 889 (31.2%) were culture positive for H. influenzae; of these, 71 (8.0%) were hpd negative. Despite the same practice throughout the study, the annual number of ME samples reduced from 660 in 2012 to 330 in 2017. The proportions of hpd-negative isolates in unvaccinated versus vaccinated children were 5.6% and 7.0%, respectively, in healthy carriers, and 5.4% and 7.8%, respectively, in ME samples. The proportion of hpd-negative isolates increased with time in ME samples but not in healthy carriers. The number of ME samples from children with AOM decreased. The PHiD-CV had no effect on the proportion of the hpd gene in H. influenzae from carriage, but there was an increase in hpd-negative H. influenzae in otitis media. The proportions of hpd-negative isolates remained similar in vaccinated and unvaccinated children. This study was funded by The Icelandic Centre for Research (grant number 152047-051) and the Landspitali University Hospital Research Fund. The collection of DCC samples was part of an investigator-initiated study, supported by GlaxoSmithKline Biologicals SA. ...
author2 Læknadeild (HÍ)
Faculty of Medicine (UI)
Lífvísindasetur (HÍ)
Biomedical Center (UI)
Heilbrigðisvísindasvið (HÍ)
School of Health Sciences (UI)
Háskóli Íslands
University of Iceland
format Article in Journal/Newspaper
author Sveinsdóttir, Hildigunnur
Björnsdóttir, Jana Birta
Erlendsdóttir, Helga
Hjálmarsdóttir, Martha Ásdís
Hrafnkelsson, Birgir
Haraldsson, Ásgeir
Kristinsson, Karl G.
Haraldsson, Gunnsteinn
author_facet Sveinsdóttir, Hildigunnur
Björnsdóttir, Jana Birta
Erlendsdóttir, Helga
Hjálmarsdóttir, Martha Ásdís
Hrafnkelsson, Birgir
Haraldsson, Ásgeir
Kristinsson, Karl G.
Haraldsson, Gunnsteinn
author_sort Sveinsdóttir, Hildigunnur
title The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
title_short The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
title_full The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
title_fullStr The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
title_full_unstemmed The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
title_sort effect of the 10-valent pneumococcal nontypeable haemophilus influenzae protein d conjugate vaccine on h. influenzae in healthy carriers and middle ear infections in iceland
publisher American Society for Microbiology
publishDate 2019
url https://hdl.handle.net/20.500.11815/1931
https://doi.org/10.1128/JCM.00116-19
genre Iceland
genre_facet Iceland
op_relation Journal of Clinical Microbiology;57(7)
https://syndication.highwire.org/content/doi/10.1128/JCM.00116-19
Sveinsdóttir H, Björnsdóttir JB, Erlendsdóttir H, Hjálmarsdóttir MÁ, Hrafnkelsson B, Haraldsson Á, Kristinsson KG, Haraldsson G. 2019. The effect of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine on H. influenzae in healthy carriers and middle ear infections in Iceland. J Clin Microbiol 57:e00116-19. https://doi.org/10.1128/JCM.00116-19.
0095-1137
1098-660X (eISSN)
https://hdl.handle.net/20.500.11815/1931
Journal of Clinical Microbiology
doi:10.1128/JCM.00116-19
op_rights info:eu-repo/semantics/openAccess
op_doi https://doi.org/20.500.11815/1931
https://doi.org/10.1128/JCM.00116-19
container_title Journal of Clinical Microbiology
container_volume 57
container_issue 7
_version_ 1766039745412988928